MetaCap

Fresenius Medical Care AG ADR (FMS)

NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD

20.44+0.31 (+1.54%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

FMS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$10.61B
Dividend yield
7.29% ($1.49)
Ex-dividend date
May 22, 2026
52-week range
20.00 – 26.42
Day range
20.38 – 20.72
Volume / Avg
1.34M / 1.17M
Beta
—

52-week range

$20.00$26.42

FMS stock today

Shares of Fresenius Medical Care (FMS) finished higher on Nov 20 at $20.44, a gain of 1.54% or $0.31 per share, versus the S&P 500's 3.70% decline. At this level, FMS sits near the bottom of its 52-week range of $20.00 to $26.42: 22.6% below the high, set on Aug 3, 2026 and 2.2% above the low. FMS is down 14.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 12.7%.

At 11.8x trailing earnings, Fresenius Medical Care trades below the peer-group median of 24.5x. Its forward P/E of 7.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Fresenius Medical Care pays an annual dividend of $1.49 per share, a 7.29% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Fresenius Medical Care

Company profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments.

Industry
Misc Health and Biotechnology Services
CEO
Mr. Shervin J. Korangy
Headquarters
Bad Homburg
Employees
106,291

Financial highlights

Full financials

In fiscal 2013, Fresenius Medical Care generated $4.97 billion in revenue, down 64.0% from fiscal 2012, the first decline in the 7 years shown. Net income was $1.11 billion (-6.5% year over year), for a net margin of 22.3% versus a median of 8.3% in the prior 5 years. Gross margin was 95.3% (up from 33.3%) and operating margin 45.4%.

Fresenius Medical Care annual revenue, net income and EPS
Fiscal yearFY 2013FY 2012FY 2011FY 2010FY 2009
Revenue$4.97B$13.80B$12.57B$11.84B$11.25B
Growth-63.98%+9.78%+6.13%+5.31%+5.99%
Net income$1.11B$1.19B$1.07B$978.52M$891.14M
EPS (diluted)$3.65$3.87$3.51$3.24$2.99

Analyst forecast

Forecast

Consensus (7 analysts)

hold

Avg. price target

$21.99+7.58%

  • Strong buy 1
  • Buy 0
  • Hold 3
  • Sell 1
  • Strong sell 2

Target range

Low $15.52High $34.60

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.64 vs —

Dividends

Dividend history
Annual dividend
$1.49
Last payment
$0.872
Ex-dividend date
May 22, 2026

FMS news

All FMS news

Fresenius Medical Care peers

Health Care sector
FMS peer companies
CompanyPrice% ChgMarket capCompare
DVADaVita Inc.161.03+3.00%$10.13Bvs FMS
SHCSotera Health Company15.91-1.85%$4.54Bvs FMS
PGNYProgyny Inc.35.71+0.73%$2.63Bvs FMS
AGLagilon health inc.90.24+0.83%$1.52Bvs FMS
VMDViemed Healthcare Inc.8.52-1.05%$322.85Mvs FMS
PARKPark Dental Partners Inc.17.03-6.79%$94.26Mvs FMS
CCELCryo-Cell International Inc.4.150.00%$33.46Mvs FMS
MGRXMangoceuticals Inc.0.1236-7.55%$2.75Mvs FMS

Indexes, lists and sector

Fresenius Medical Care stock FAQ

What is Fresenius Medical Care's stock price today?

FMS last traded at $20.44 as of Nov 20, 4:00 PM EST, up 1.54% on the day. Prices are delayed at least 15 minutes.

Does Fresenius Medical Care pay a dividend?

Yes. Fresenius Medical Care pays $1.49 per share annually, a 7.29% yield. The most recent dividend of $0.872 had an ex-dividend date of May 22, 2026.

What is FMS's P/E ratio?

FMS trades at a trailing P/E ratio of 11.82 and a forward P/E of 7.77, compared with a median of 24.5 for its closest peers.

Who is Fresenius Medical Care's CEO?

Mr. Shervin J. Korangy is the chief executive officer of Fresenius Medical Care AG ADR, which has about 106,291 employees.

Has FMS ever split its stock?

Yes. The most recent FMS stock split was a 2-for-1 split on Dec 4, 2012.

What is the FMS 52-week high?

The 52-week high for FMS is $26.42 and the 52-week low is $20.00. The stock is currently 22.6% below its high.

Compare FMS